SCNI
Scinai Immunotherapeutics
SCNI
SCNI
16 hedge funds and large institutions have $891K invested in Scinai Immunotherapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$259K | |
| 2 | +$33K | |
| 3 | +$29K | |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$14K |
| 5 |
TPWA
TRUE Private Wealth Advisors
Salem,
Oregon
|
+$8.6K |
Top Sellers
| 1 | -$111K | |
| 2 | -$103K | |
| 3 | -$70K | |
| 4 |
Two Sigma Advisers
New York
|
-$42K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$37K |